… Schematic representation of dermatologic adverse events associated with fibroblast growth
factor receptor inhibition. Suggested dose modifications for dermatologic adverse events: …

Because of their increased activity against activating mutants, first-generation epidermal
growth factor receptor (EGFR) kinase inhibitors have had remarkable success in treating non-…

Purpose: BAY 43-9006, a novel multikinase inhibitor, prevents tumor growth by combining
two antitumor activities: inhibition of both tumor cell proliferation and tumor angiogenesis. This …

… factor for HCC is cirrhosis and several lines of evidence implicate epidermal growth factor
(… We therefore examined the effects of the EGF receptor (EGFR) inhibitor erlotinib on liver …

… first agents targeting the epidermal growth factor receptor (EGFR) … that antibodies inhibiting
the pathway could retard cell growth, … in the tumors rather than a failure of receptor inhibition. …

… of hair growth, Itching, and Dryness due to Epidermal growth factor receptor inhibitors) …
the small molecule epidermal growth factor receptor (EGFR) inhibitor erlotinib (upper panel)…

… Epidermal growth factor receptor (EGFR) inhibitor therapy has become the standard treatment
for … is a marker of effectiveness of therapy with epidermal growth factor receptor inhibitor. …

… growth factor receptor (EGFR) has been selected as a potential target for chemoprevention.
Because growth factor networks are redundant, selective inhibition … EGFR inhibitors include …

… These reversible tyrosine kinase inhibitors (TKIs) selectively target HER1 (human epidermal
growth factor receptor [EGFR, ErbB1]), one of the four HER family receptors (EGFR, ErbB1, …

Background: Rosacea-like papulopustular eruptions (rash) are considered the most frequent
toxicities associated with the use of inhibitors of the epidermal growth factor receptor (EGFR…